<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway is involved in immune function and cell growth </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the association between genetic variation in JAK1 (10 SNPs), JAK2 (9 SNPs), TYK2 (5 SNPs), suppressors of cytokine signaling (SOCS)1 (2 SNPs), SOCS2 (2 SNPs), STAT1 (16 SNPs), STAT2 (2 SNPs), STAT3 (6 SNPs), STAT4 (21 SNPs), STAT5A (2 SNPs), STAT5B (3 SNPs), STAT6 (4 SNPs) with risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We used data from population-based case-control studies (<z:hpo ids='HP_0003003'>colon cancer</z:hpo> n = 1555 cases, 1,956 controls; <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> n = 754 cases, 959 controls) </plain></SENT>
<SENT sid="3" pm="."><plain>JAK2, SOCS2, STAT1, STAT3, STAT5A, STAT5B, and STAT6 were associated with <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; STAT3, STAT4, STAT6, and TYK2 were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Given the biological role of the JAK/STAT-signaling pathway and cytokines, we evaluated interaction with IFNG, TNF, and IL6; numerous statistically significant associations after adjustment for multiple comparisons were observed </plain></SENT>
<SENT sid="5" pm="."><plain>The following statistically significant interactions were observed: TYK2 with aspirin/<z:chebi fb="1" ids="35475">NSAID</z:chebi> use; STAT1, STAT4, and TYK2 with <z:chebi fb="0" ids="50114">estrogen</z:chebi> status; and JAK2, STAT2, STAT4, STAT5A, STAT5B, and STAT6 with smoking status and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk; JAK2, STAT6, and TYK2 with aspirin/<z:chebi fb="1" ids="35475">NSAID</z:chebi> use; JAK1 with <z:chebi fb="0" ids="50114">estrogen</z:chebi> status; STAT2 with cigarette smoking and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>JAK2, SOCS1, STAT3, STAT5, and TYK2 were associated with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> survival (hazard rate ratio (HRR) of 3.3 95% CI 2.01,5.42 for high mutational load) </plain></SENT>
<SENT sid="7" pm="."><plain>JAK2, SOCS1, STAT1, STAT4, and TYK2 were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> survival (HRR 2.80 95% CI 1.63,4.80) </plain></SENT>
<SENT sid="8" pm="."><plain>These data support the importance of the JAK/STAT-signaling pathway in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and suggest targets for intervention </plain></SENT>
</text></document>